Cargando…

Status of Onchocerciasis Transmission after More Than a Decade of Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis Elimination in Central Nigeria: Challenges in Coordinating the Stop MDA Decision

BACKGROUND: This study was undertaken in five onchocerciasis/lymphatic filariasis (LF) co-endemic local government areas (LGAs) in Plateau and Nasarawa, Nigeria. Annual MDA with ivermectin had been given for 17 years, 8 of which were in combination with albendazole. In 2008, assessments indicated th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evans, Darin S., Alphonsus, Kal, Umaru, Jon, Eigege, Abel, Miri, Emmanuel, Mafuyai, Hayward, Gonzales-Peralta, Carlos, Adamani, William, Pede, Elias, Umbugadu, Christopher, Saka, Yisa, Okoeguale, Bridget, Richards, Frank O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169246/ https://www.ncbi.nlm.nih.gov/pubmed/25233351 http://dx.doi.org/10.1371/journal.pntd.0003113

Ejemplares similares

Long-Lasting Insecticidal Nets Are Synergistic with Mass Drug Administration for Interruption of Lymphatic Filariasis Transmission in Nigeria
por: Eigege, Abel, et al.
Publicado: (2013)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin
por: Wilson, Nana O., et al.
Publicado: (2016)

The Interruption of Transmission of Human Onchocerciasis by an Annual Mass Drug Administration Program in Plateau and Nasarawa States, Nigeria
por: Richards, Frank O., et al.
Publicado: (2020)

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso
por: Nikièma, Achille S., et al.
Publicado: (2021)

Anti-Wolbachia therapy for onchocerciasis & lymphatic filariasis: Current perspectives
por: Wan Sulaiman, Wan Aliaa, et al.
Publicado: (2019)

Repurposing Auranofin as a Lead Candidate for Treatment of Lymphatic Filariasis and Onchocerciasis
por: Bulman, Christina A., et al.
Publicado: (2015)

Integrated transmission assessment surveys (iTAS) of lymphatic filariasis and onchocerciasis in Cross River, Taraba and Yobe States, Nigeria
por: Anagbogu, Ifeoma N., et al.
Publicado: (2022)

A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis
por: Halliday, Alice, et al.
Publicado: (2014)

Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis
por: TAYLOR, MARK J., et al.
Publicado: (2014)

Boron-Pleuromutilins as Anti-Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis
por: Jacobs, Robert T., et al.
Publicado: (2019)

Serological Evaluation of Onchocerciasis and Lymphatic Filariasis Elimination in the Bakoye and Falémé Foci, Mali
por: Dolo, Housseini, et al.
Publicado: (2020)

Assessment of the burden of soil-transmitted helminthiasis after five years of mass drug administration for Onchocerciasis and Lymphatic filariasis in Kebbi State, Nigeria
por: Oluwole, Akinola Stephen, et al.
Publicado: (2017)

The interruption of transmission of onchocerciasis in Kaduna, Kebbi and Zamfara states, Nigeria: another milestone achievement
por: Isiyaku, Sunday, et al.
Publicado: (2022)

Epidemiological and Entomological Evaluations after Six Years or More of Mass Drug Administration for Lymphatic Filariasis Elimination in Nigeria
por: Richards, Frank O., et al.
Publicado: (2011)

Mass ivermectin treatment for Onchocerciasis: Lack of evidence for collateral impact on transmission of Wuchereria bancrofti in areas of co-endemicity
por: Richards, FO, et al.
Publicado: (2005)

Navigating the way to onchocerciasis elimination: the feasibility and affordability of Onchocerciasis Elimination Mapping
por: Hamill, Louise, et al.
Publicado: (2022)

Eliminating Lymphatic Filariasis, Onchocerciasis, and Schistosomiasis from the Americas: Breaking a Historical Legacy of Slavery
por: Lammie, Patrick J., et al.
Publicado: (2007)

Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis
por: Johnston, Kelly L., et al.
Publicado: (2014)

Post-Treatment Surveillance for Lymphatic Filariasis in Plateau and Nasarawa States, Nigeria: Results of Transmission Assessment Surveys
por: Eigege, Abel, et al.
Publicado: (2020)

Developing Eradication Investment Cases for Onchocerciasis, Lymphatic Filariasis, and Human African Trypanosomiasis: Rationale and Main Challenges
por: Tediosi, Fabrizio, et al.
Publicado: (2013)

MDA—Lymphatic Filariasis
por: Ichimori, Kazuyo
Publicado: (2014)

Lymphatic filariasis baseline survey in two sentinel sites of Ogun state, Nigeria
por: Okorie, Patricia Nkem, et al.
Publicado: (2015)

Impact of Three Rounds of Mass Drug Administration on Lymphatic Filariasis in Areas Previously Treated for Onchocerciasis in Sierra Leone
por: Koroma, Joseph B., et al.
Publicado: (2013)

Loa loa vectors Chrysops spp.: perspectives on research, distribution, bionomics, and implications for elimination of lymphatic filariasis and onchocerciasis
por: Kelly-Hope, Louise, et al.
Publicado: (2017)

Onchocerciasis
Publicado: (1911)

Contributions of different mosquito species to the transmission of lymphatic filariasis in central Nigeria: implications for monitoring infection by PCR in mosquito pools
por: Lenhart, Audrey, et al.
Publicado: (2007)

Progress towards elimination of onchocerciasis transmission in Mali: A “pre-stop MDA” survey in 18 transmission zones
por: Dolo, Housseini, et al.
Publicado: (2023)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa
por: Fischer, Peter U., et al.
Publicado: (2017)

Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d’Ivoire
por: Loukouri, Agodio, et al.
Publicado: (2020)

Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions
por: Biamonte, Marco A., et al.
Publicado: (2022)

Two Nigerian States (Plateau and Nasarawa) Have Eliminated Transmission of Human Onchocerciasis—A Report of Post-Ivermectin Mass Drug Administration Surveillance
por: Miri, Emmanuel S., et al.
Publicado: (2023)

Challenges to Making the Decision to Stop Mass Drug Administration for Onchocerciasis: Lessons Learned from Nigeria
por: Evans, Darin S.
Publicado: (2020)

2) Onchocerciasis
por: Tada, Isao
Publicado: (2015)

3) Onchocerciasis
por: Tada, Isao
Publicado: (2015)

Correction: Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions
por: Biamonte, Marco A., et al.
Publicado: (2023)

Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis
por: Aljayyoussi, Ghaith, et al.
Publicado: (2017)

Information for onchocerciasis control
por: Hopkins, Adrian
Publicado: (2010)

Onchocerciasis: the beginning of the end?
por: Hopkins, Adrian
Publicado: (2019)

Investing in Onchocerciasis Control: Financial Management of the African Programme for Onchocerciasis Control (APOC)
por: Bundy, Donald A. P., et al.
Publicado: (2015)

Corrigendum to: Navigating the way to onchocerciasis elimination: the feasibility and affordability of Onchocerciasis Elimination Mapping
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ahfgbvbl19jp8051rqn0g2t4ak